Directory
Anabel Sorolla Bardaji

Anabel Sorolla Bardaji

Degree: PhD


asorolla(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/E-2546-2012

Groups

Publications

  • Yeramian, Andree; Sorolla, Anabel; Velasco, Ana; Santacana, Maria; Dolcet, Xavier; Valls, Joan; Abal, Leandre; Moreno, Sara; Egido, Ramon; Casanova, Josep M.; Puig, Susana; Vilella, Ramon; Llombart-Cussac, Antonio; Matias-Guiu, Xavier; Marti, Rosa M.

    Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway

    INTERNATIONAL JOURNAL OF CANCER 130 967-978. .

    [doi:10.1002/ijc.26096]

  • Das, A; Sorolla, A; Herreros, J; Vilella, R; Matias-Guiu, X; Marti, RM; Canti, C

    Role of voltage-gated calcium channels in the viability of melanoma

    JOURNAL OF INVESTIGATIVE DERMATOLOGY 131 109-109. .

  • Yeramian, Andree; Santacana, Maria; Sorolla, Anabel; Llobet, David; Encinas, Mario; Velasco, Ana; Bahi, Nuria; Eritja, Nuria; Domingo, Monica; Oliva, Esther; Dolcet, Xavier; Matias-Guiu, Xavier

    Nuclear factor-?B2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1a independent manner.

    LABORATORY INVESTIGATION 91 859-871. .

    [doi:10.1038/labinvest.2011.58]

  • Llobet, D.; Eritja, N.; Yeramian, A.; Pallares, J.; Sorolla, A.; Domingo, M.; Santacana, M.; Gonzalez-Tallada, F. J.; Matias-Guiu, X.; Dolcet, X.

    The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms.

    EUROPEAN JOURNAL OF CANCER 46 836-850. .

    [doi:10.1016/j.ejca.2009.12.025]

  • Martinez-Alonso, M.; Llecha, N.; Mayorga, M. E.; Sorolla, A.; Dolcet, X.; Sanmartin, V.; Abal, L.; Casanova, J. M.; Baradad, M.; Yeramian, A.; Egido, R.; Puig, S.; Vilella, R.; Matias-Guiu, X.; Marti, R. M.

    Expression of somatostatin receptors in human melanoma cell lines: effect of two different somatostatin analogues, octreotide and SOM230, on cell proliferation.

    Journal Of International Medical Research 37 1813-1822. .

    [doi:10.1177/147323000903700617]

  • Pallares, Judit; Santacana, Maria; Puente, Soraya; Lopez, Susana; Yeramian, Andree; Eritja, Nuria; Sorolla, Anabel; Llobet, David; Dolcet, Xavier; Matias-Guiu, Xavier

    A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinoma.

    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY 31 217-226. .

  • Ortega, Eugenia; Marti, Rosa M.; Yeramian, Andree; Sorolla, Anabel; Dolcet, Xavier; Llobet, David; Abal, Leandro; Santacana, Maria; Pallares, Judit; Llombart-Cussac, Antonio; Matias-Guiu, Xavier

    Targeted therapies in gynecologic cancers and melanoma.

    SEMIN DIAGN PATHOL 25 262-273. .

    [doi:10.1053/j.semdp.2008.07.008]

  • Velasco, Ana; Pallares, Judit; Santacana, Maria; Yeramian, Andre; Dolcet, Xavier; Eritja, Nuria; Puente, Soraya; Sorolla, Anabel; Llecha, Nuria; Matias-Guiu, Xavier

    Loss of heterozygosity in endometrial carcinoma

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 27 305-317. .

    [doi:10.1097/PGP.0b013e31815dafla]

  • Velasco A; Pallares J; Santacana M; Yeramian A; Dolcet X; Eritja N; Puente S; Sorolla A; Llecha N; Matias-Guiu X

    Loss of heterozygosity in endometrial carcinoma.

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 27 305-317. .

    [doi:10.1097/PGP.0b013e31815daf1a]

  • Llobet, D.; Eritja, N.; Encinas, M.; Llecha, N.; Yeramian, A.; Pallares, J.; Sorolla, A.; Gonzalez-Tallada, F. J.; Matias-Guiu, X.; Dolcet, X.

    CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells.

    ONCOGENE 27 2513-2524. .

    [doi:10.1038/sj.onc.1210924]

  • Sorolla, A.; Yeramian, A.; Dolcet, X.; Perez de Santos, A. M.; Llobet, D.; Schoenenberger, J. A.; Casanova, J. M.; Soria, X.; Egido, R.; Llombart, A.; Vilella, R.; Matias-Guiu, X.; Marti, R. M.

    Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines.

    BRITISH JOURNAL OF DERMATOLOGY 158 496-504. .

    [doi:10.1111/j.1365-2133.2007.08390.x]

  • Llobet, David; Eritja, Nuria; Encinas, Mario; Sorolla, Anabel; Yeramian, Andree; Antoni Schoenenberger, Joan; Llombart-Cussacc, Antonio; Martia, Rosa M.; Matias-Guiu, Xavier; Dolcet, Xavier

    Antioxidants block proteasome inhibitor function in endometrial carcinoma cells.

    ANTI-CANCER DRUGS 19 115-124. .

    [doi:10.1097/CAD.0b013e3282f24031]

Projects

  • DEVELOPMENT OF PRECISION THERAPIES FOR TRIPLE NEGATIVE BREAST CANCERS BASED ON CRISPR/CAS9 RIBONUCLEOPROTEINS.
  • Ajuts contractació personal investigador predoctoral en formació (FI2022)
  • Development of precision therapies for triple negative breast cancer based on CRISPR/Cas12a ribonucleoproteins
  • Contrato Miguel Servet - Proyecto + RRHH
  • EXPRESION DE CANALES DE CALCIO DE TIPO T EN NEOPLASIAS MELANOCÍTICAS BENIGNAS Y MALIGNAS. EVALUACION DE SU APLICICABILIDAD CLINICA COMO DIANAS TERAPEUTICAS EN EL MELANOMA